Effect of small doses of somatostatin analog, octreotide, on gallbladder contractility in normal Chinese adults

This publication has 12 references indexed in Scilit:

• Long Term Effect of Incremental Doses of the Somatostatin Analog SMS 201–995 in 58 Acromegalic Patients*
  Journal of Clinical Endocrinology & Metabolism, 1990
• CLINICAL AND BIOCHEMICAL EFFECTS OF INCREMENTAL DOSES OF THE LONG-ACTING SOMATOSTATIN ANALOGUE SMS 201-995 IN TEN ACROMEGALIC PATIENTS
  Clinical Endocrinology, 1990
• Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
  Annals of Internal Medicine, 1990
• Postprandial Gallbladder Motility during Long Term Treatment with the Long-Acting Somatostatin Analog SMS 201-995 in Acromegaly
  Journal of Clinical Endocrinology & Metabolism, 1989
• Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
  Annals of Internal Medicine, 1989
• Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group
  Published by Springer Nature ,1988
• Effect of the Somatostatin Analogue Sandostatin (SMS 201–995) on Gastrointestinal, Pancreatic and Biliary Function and Hormone Release in Normal Men
  Digestion, 1987
• Specific somatostatin-binding to cytosol of bovine gallbladder mucosa
  Bioscience Reports, 1986
• Sonographic measurement of gallbladder volume
  American Journal of Roentgenology, 1985
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982